News
![Boehringer Ingelheim licenses multiple Dark Antigens® from Enara Bio to develop off-the-shelf immunotherapies for non-small cell lung cancer (NSCLC)](https://enarabio.ams3.cdn.digitaloceanspaces.com/uploads/1098231/EnaraBio-Boehringer-Ingelheim-Thumbnail_a1d2ae143477d5210ae88a062e48e32b.png)
![Enara Bio, ROME Therapeutics and Nucleome Therapeutics to Host 2nd Annual Dark Genome Symposium](https://enarabio.ams3.cdn.digitaloceanspaces.com/uploads/983756/dark-genome-thumbnail_a1d2ae143477d5210ae88a062e48e32b.jpg)
All News
Browse our full news archives
Publications
Scientific posters highlighting our Dark Antigens as novel immunotherapy targets for solid tumors
![Identification and validation of specific Dark Antigen™ reactive TCRs](https://enarabio.ams3.cdn.digitaloceanspaces.com/uploads/1066447/POSTER-SITC-2023_417d3c2b8c376bb0f14cc3ecd26d6ae0.jpg)
![Identification and validation of Dark Antigens™ in multiple solid tumors](https://enarabio.ams3.cdn.digitaloceanspaces.com/uploads/513216/CleanShot-2023-06-11-at-20.28.55_2023-06-28-054608_fdym_417d3c2b8c376bb0f14cc3ecd26d6ae0.jpg)
![Identification of tumor-reactive T cells targeting melanoma Dark Antigens™](https://enarabio.ams3.cdn.digitaloceanspaces.com/uploads/28430/EnaraBio-343-SITC-2022-Poster_417d3c2b8c376bb0f14cc3ecd26d6ae0.jpg)
![Our early research discovering immunogenic ERV-derived antigens](https://enarabio.ams3.cdn.digitaloceanspaces.com/uploads/513254/ERV-Derived-Publication-Cover_417d3c2b8c376bb0f14cc3ecd26d6ae0.jpg)
A short selection of the growing scientific literature that inspires us to shine a light on genomic dark matter
Upcoming & Recent Events
Discover the events that the Enara Bio team are attending